Castle Biosciences Inc (NASDAQ:CSTL) shares, rose in value, with the stock price up by 1.18% to the previous day’s close as strong demand from buyers drove the stock to $21.51.
Actively observing the price movement in the last trading, the stock closed the session at $21.26, falling within a range of $21.13 and $21.81. The value of beta (5-year monthly) was 1.106 whereas the PE ratio was 35.10 over 12-month period. Referring to stock’s 52-week performance, its high was $35.84, and the low was $16.97. On the whole, CSTL has fluctuated by 4.72% over the past month.
With the market capitalization of Castle Biosciences Inc currently standing at about $620.45 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 288.77M, with a low estimate of 69.2M and a high estimate of 85.25M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 80.4M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CSTL’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of CSTL currently trading nearly 7.36% and -2.84% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 56.26, while the 7-day volatility ratio is showing 4.68% which for the 30-day chart, stands at 5.63%. Furthermore, Castle Biosciences Inc (CSTL)’s beta value is 1.12, and its average true range (ATR) is 1.21.
A comparison of Castle Biosciences Inc (CSTL) with its peers suggests the former has fared considerably weaker in the market. CSTL showed an intraday change of 1.18% in last session, and over the past year, it grew by 13.57%%.
Data on historical trading for Castle Biosciences Inc (NASDAQ:CSTL) indicates that the trading volumes over the past 10 days have averaged 0.4 and over the past 3 months, they’ve averaged 408.24K. According to company’s latest data on outstanding shares, there are 28.48 million shares outstanding.
Nearly 3.02% of Castle Biosciences Inc’s shares belong to company insiders and institutional investors own 98.53% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.67 million shares as on 2025-03-31, resulting in a short ratio of 3.62. According to the data, the short interest in Castle Biosciences Inc (CSTL) stood at 604.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 1.85 million. The stock has fallen by -19.29% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CSTL stock heading into the next quarter.
